# US 2019/0336657 A1 · Drug delivery system and method of manufacturing thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0336657 A1
- Document ID: US20190336657A1
- Status: Published application
- Kind: A1
- Application number: 16/502,696
- Filed: 2019-07-03
- Published: 2019-11-07
- Earliest claimed: 2011-08-22
- Assignees: Exogenesis Corporation
- Applicants: Exogenesis Corporation
- Inventors: Richard C. Svrluga; Sean R. Kirkpatrick; Stephen M. Blinn
- Web page: https://patentgrep.com/patent/US20190336657A1

## CPC

- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61K 31/436: the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 2300/602: Type of release, e.g. controlled, sustained, slow
- A61L 2300/606: Coatings
- A61L 2300/61: containing two or more active agents in different layers
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- A61L 2420/02: Methods for coating medical devices
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A method of modifying the surface of a medical device to release a drug in a controlled way by providing a barrier layer on the surface of one or more drug coatings. The barrier layer consists of modified drug material converted to a barrier layer by irradiation by an accelerated neutral beam derived from an accelerated gas cluster ion beam. Also medical devices formed thereby.

## Claims

### Claim 1

A medical device having a surface adapted for delivering one or more drugs, comprising: and one or more drug coating layers on the surface of the device, at least one of the drug coating layers having at least one barrier layer adapted for controlling a rate of flow of material across the at least one barrier layer, and further wherein the at least one barrier layer consists of drug modified by Neutral Beam irradiation.

### Claim 2 (depends on 1)

The medical device of claim 1, wherein the at least one barrier layer:
controls a release rate of drugs;
controls an elution rate of drugs; or
controls an inward diffusion rate of a fluid into at least one of the one or more drug coating layers.

### Claim 3 (depends on 1)

The medical device of claim 1, wherein at least one drug coating layer of the one or more drug coating layers contains a first quantity of a first drug, said first drug overlaid by a first barrier layer comprising modified first drug, said first barrier layer overlaid by a second quantity of a second drug, said second drug overlaid by a second barrier layer comprising modified second drug.

### Claim 4 (depends on 3)

The medical device of claim 3, wherein:
the first drug and the second drug are the same drug or different drugs; and
the first barrier layer and the second barrier layer are constructed to control a temporal release profile of the first and second drugs.

### Claim 5 (depends on 1)

The medical device of claim 1, wherein the controlled flow rate is:
a drug elution rate;
a drug release rate; or
a fluid diffusion rate.

### Claim 6 (depends on 1)

The medical device of claim 1, wherein the medical device is any of:
a vascular stent;
a coronary stent;
an artificial joint prosthesis;
an artificial joint prosthesis component; or
a coronary pacemaker.

### Claim 7 (depends on 1)

The medical device of claim 1, wherein the at least one barrier layer comprising modified drug is selected from the group consisting of:
cross-linked drug molecules;
a densified drug;
a carbonized organic drug material;
a polymerized drug; or
a denaturized drug; and
combinations thereof.

### Claim 8 (depends on 1)

The medical device of claim 1, wherein the at least one barrier layer comprises a biologically active material.
